Vanda Pharmaceuticals (VNDA) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $293.8 million.
- Vanda Pharmaceuticals' Cash & Current Investments fell 2192.87% to $293.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.8 million, marking a year-over-year decrease of 2192.87%. This contributed to the annual value of $374.6 million for FY2024, which is 350.82% down from last year.
- Vanda Pharmaceuticals' Cash & Current Investments amounted to $293.8 million in Q3 2025, which was down 2192.87% from $325.6 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Cash & Current Investments high stood at $501.5 million for Q1 2023, and its period low was $293.8 million during Q3 2025.
- In the last 5 years, Vanda Pharmaceuticals' Cash & Current Investments had a median value of $396.5 million in 2021 and averaged $409.1 million.
- In the last 5 years, Vanda Pharmaceuticals' Cash & Current Investments soared by 2107.93% in 2021 and then crashed by 2318.98% in 2024.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Cash & Current Investments stood at $432.8 million in 2021, then increased by 7.87% to $466.9 million in 2022, then decreased by 16.83% to $388.3 million in 2023, then fell by 3.51% to $374.6 million in 2024, then dropped by 21.59% to $293.8 million in 2025.
- Its Cash & Current Investments stands at $293.8 million for Q3 2025, versus $325.6 million for Q2 2025 and $340.9 million for Q1 2025.